How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs
The hypothesis posits that gut dysbiosis depletes SCFA-producing commensals, reducing SCFA-mediated activation of microglial GPR43/GPR41 receptors and HDAC inhibition. This removes inhibitory checkpoints on NF-κB, permitting unchecked pro-inflammatory cytokine production.
---
| Dimension | Score | Rationale |
|-----------|-------|-----------|
| Mechanistic Plausibility | 0.81 | Logically coherent pathway; integrates receptor-mediated G-protein signaling with epigenetic regulation. GPR43/41 → NF-κB axis is biologically supported, though HDAC3 specificity in microglia requires validation. |
| Evidence Strength | 0.72 | Strong biochemical evidence for SCFA-HDAC-NF-κB relationships. Moderate evidence from germ-free/antibiotic mouse models. Limited direct human evidence; causality in neurodegeneration remains associative. |
| Novelty | 0.65 | Modestly novel; builds on established gut-brain axis literature. The dual braking mechanism (receptor + epigenetic) adds conceptual refinement rather than paradigm shift. |
| Feasibility | 0.78 | Highly testable in animal models (GF mice, FMT, SCFA supplementation). Human translational studies are feasible but expensive. GPR43 knockout/agonist studies are technically mature. |
| Therapeutic Potential | 0.84 | High potential: butyrate supplementation, prebiotics, probiotics, GPR43 agonists. Blood-brain barrier